Koers Invictus MD Strategies Corp Toronto S.E.
Aandelen
GENE
CA46183X2086
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- CAD | - |
Omzet 2018 | 2,36 3,22 2,17 | Omzet 2019 | 4,69 6,39 4,31 | Marktkapitalisatie | 104 mln. 141 mln. 95,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -19 mln. -25,89 mln. -17,45 mln. | Nettowinst (verlies) 2019 | -35 mln. -47,7 mln. -32,14 mln. | EV/omzet 2018 | 45.833.024 x |
Nettoliquiditeiten 2018 | 37,59 mln. 51,23 mln. 34,53 mln. | Nettoschuld 2019 | 3,85 mln. 5,24 mln. 3,53 mln. | EV/omzet 2019 | 22.877.117 x |
K/w-verhouding 2018 |
-5,87
x | K/w-verhouding 2019 |
-2,45
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 6,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 09-05-19 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 24-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 09-05-19 |
Jagdeep Gupta
BRD | Director/Board Member | - | 22-02-22 |
Greg Macdonald
BRD | Director/Board Member | - | 26-01-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,12% | 6,02 mld. | |
-22,80% | 4,19 mld. | |
+5,44% | 3,25 mld. | |
-19,45% | 2,87 mld. | |
-10,35% | 2,37 mld. | |
+42,72% | 1,89 mld. | |
-5,87% | 1,58 mld. | |
-18,53% | 1,54 mld. | |
-15,33% | 1,5 mld. |
- Beurs
- Aandelen
- Koers IVITF
- Koers GENE